Terms: = Lymphoma AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Prognosis
23 results:
1. Effect of Peripheral Blood Lymphocytes on prognosis of Multiple Cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract] [Full Text] [Related]
2. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
Courtois L; Cabannes-Hamy A; Kim R; Delecourt M; Pinton A; Charbonnier G; Feroul M; Smith C; Tueur G; Pivert C; Balducci E; Simonin M; Angel LH; Spicuglia S; Boissel N; Andrieu GP; Asnafi V; Rousselot P; Lhermitte L
Blood; 2023 Jul; 142(2):158-171. PubMed ID: 37023368
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell lymphoma.
Luo C; Nie H; Yu L
Oxid Med Cell Longev; 2022; 2022():3334522. PubMed ID: 35069971
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
[TBL] [Abstract] [Full Text] [Related]
5. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).
Genescà E; Morgades M; González-Gil C; Fuster-Tormo F; Haferlach C; Meggendorfer M; Montesinos P; Barba P; Gil C; Coll R; Moreno MJ; Martínez-Carballeira D; García-Cadenas I; Vives S; Ribera J; González-Campos J; Díaz-Beya M; Mercadal S; Artola MT; Cladera A; Tormo M; Bermúdez A; Vall-Llovera F; Martínez-Sánchez P; Amigo ML; Monsalvo S; Novo A; Cervera M; García-Guiñon A; Ciudad J; Cervera J; Hernández-Rivas JM; Granada I; Haferlach T; Orfao A; Solé F; Ribera JM
Leuk Res; 2021 Oct; 109():106612. PubMed ID: 34139642
[TBL] [Abstract] [Full Text] [Related]
6. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract] [Full Text] [Related]
7. [Gene Mutation in Acute Lymphoblastic Leukemia by DNA Sequencing].
Zheng RY; Wang SJ; Wang C; Li T; Liao LX; Li ML; Chen SM; Guo R; Wang WQ; Zhang Y; Fan Y; Wan DM; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1791-1795. PubMed ID: 33283700
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of Clinical Characteristics and Therapeutic Efficacy of Patients with Adult Acute Lymphoblastic Leukemia].
Xu TT; Wang WM; Fu GM; Wang JM; Jiang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):68-75. PubMed ID: 32027255
[TBL] [Abstract] [Full Text] [Related]
9. Adult T-cell acute lymphoblastic leukemias with il7r pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
Kim R; Boissel N; Touzart A; Leguay T; Thonier F; Thomas X; Raffoux E; Huguet F; Villarese P; Fourrage C; Passini L; Hunault M; Lepretre S; Chevallier P; Braun T; Lhéritier V; Chantepie S; Maury S; Escoffre M; Tavernier E; Chalandon Y; Graux C; Macintyre E; Ifrah N; Asnafi V; Dombret H; Lhermitte L;
Leukemia; 2020 Jul; 34(7):1730-1740. PubMed ID: 31992840
[TBL] [Abstract] [Full Text] [Related]
10. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract] [Full Text] [Related]
11. CD4
Niedźwiecki M; Budziło O; Adamkiewicz-Drożyńska E; Pawlik-Gwozdecka D; Zieliński M; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
J Immunol Res; 2019; 2019():2816498. PubMed ID: 30944830
[TBL] [Abstract] [Full Text] [Related]
12. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract] [Full Text] [Related]
13. Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
Kagdi HH; Demontis MA; Fields PA; Ramos JC; Bangham CR; Taylor GP
Cancer Med; 2017 Jan; 6(1):298-309. PubMed ID: 28035765
[TBL] [Abstract] [Full Text] [Related]
14. Follicular B lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract] [Full Text] [Related]
15. Increased regulatory T cells in acute lymphoblastic leukaemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2016 May; 21(4):206-12. PubMed ID: 26907959
[TBL] [Abstract] [Full Text] [Related]
16. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
[TBL] [Abstract] [Full Text] [Related]
17. Targeted sequencing identifies associations between il7r-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
[TBL] [Abstract] [Full Text] [Related]
18. Increased regulatory T cells in acute lymphoblastic leukemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2015 Oct; 20(9):523-9. PubMed ID: 26119924
[TBL] [Abstract] [Full Text] [Related]
19. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with cd127 as alternative to transcription factor FoxP3.
Dasgupta A; Mahapatra M; Saxena R
Leuk Lymphoma; 2013 Apr; 54(4):778-89. PubMed ID: 22989355
[TBL] [Abstract] [Full Text] [Related]
20. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
van Bodegom D; Zhong J; Kopp N; Dutta C; Kim MS; Bird L; Weigert O; Tyner J; Pandey A; Yoda A; Weinstock DM
Blood; 2012 Oct; 120(14):2853-63. PubMed ID: 22915648
[TBL] [Abstract] [Full Text] [Related]
[Next]
